Eucrates Biomedical Acquisition Corp. (EUCR)

NASDAQ: EUCR · IEX Real-Time Price · USD
10.02
0.00 (0.00%)
Jan 26, 2023, 4:00 PM EST - Market closed

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 20212020
Selling, General & Admin
0.740.15
Operating Expenses
0.740.15
Operating Income
-0.74-0.15
Other Expense / Income
-4.574.77
Pretax Income
3.82-4.92
Net Income
3.82-4.92
Shares Outstanding (Basic)
138
Shares Outstanding (Diluted)
138
Shares Change
69.68%-
EPS (Basic)
0.28-0.62
EPS (Diluted)
0.28-0.62
Free Cash Flow Per Share
-0.04-0.07
EBITDA
3.82-4.92
EBIT
3.82-4.92
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).